Search alternatives:
significant cases » significant cause (Expand Search), significant based (Expand Search), significant changes (Expand Search)
changes decrease » larger decrease (Expand Search), change increases (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
cases increased » rate increased (Expand Search), levels increased (Expand Search)
Showing 141 - 160 results of 44,048 for search '(( significant ((changes decrease) OR (largest decrease)) ) OR ( significant cases increased ))', query time: 0.97s Refine Results
  1. 141
    Raw data of frequencies of peripheral blood immune cells with each profile for DCV/ASV treatment.

    Raw data of frequencies of peripheral blood immune cells with each profile for DCV/ASV treatment. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 142
    Frequencies of peripheral blood immune cells with each profile in the non-SVR group before and after OBV/PTV/r therapy.

    Frequencies of peripheral blood immune cells with each profile in the non-SVR group before and after OBV/PTV/r therapy. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 143
    Frequencies of peripheral blood immune cells with each profile in all patients before and after OBV/PTV/r therapy by paired comparison analysis for each patient.

    Frequencies of peripheral blood immune cells with each profile in all patients before and after OBV/PTV/r therapy by paired comparison analysis for each patient. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 144
    Frequencies of peripheral blood immune cells with each profile in patients before and after DCV/ASV therapy.

    Frequencies of peripheral blood immune cells with each profile in patients before and after DCV/ASV therapy. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 145
    Consolidated standard of reporting trials (CONSORT) diagram.

    Consolidated standard of reporting trials (CONSORT) diagram. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 146
    Patient characteristics for OBV/PTV/r treatment.

    Patient characteristics for OBV/PTV/r treatment. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 147
    Graphical representation of before OBV/PTV/r treatment by Gene Ontology (GO) enrichment of differentially expressed genes between the SVR and non-SVR groups and analysis of the candidate gene.

    Graphical representation of before OBV/PTV/r treatment by Gene Ontology (GO) enrichment of differentially expressed genes between the SVR and non-SVR groups and analysis of the can... by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 148
    Raw data of frequencies of peripheral blood immune cells with each profile for OBV/PTV/r treatment.

    Raw data of frequencies of peripheral blood immune cells with each profile for OBV/PTV/r treatment. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 149
    Frequencies of peripheral blood immune cells with each profile in all patients before and after OBV/PTV/r treatment.

    Frequencies of peripheral blood immune cells with each profile in all patients before and after OBV/PTV/r treatment. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 150
    Peripheral blood immune cell profiles.

    Peripheral blood immune cell profiles. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 151
    Types of changes in GSWB and related R-G land patterns in Jinan.

    Types of changes in GSWB and related R-G land patterns in Jinan. by Shuang Lu (504608)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  12. 152
    Percentage change in COVID-19 laCFR given a 1 unit increase in the variable for each individual variable (shown in black dots) and 95% confidence interval (shown in red), using training data.

    Percentage change in COVID-19 laCFR given a 1 unit increase in the variable for each individual variable (shown in black dots) and 95% confidence interval (shown in red), using tra... by Jess A. Millar (2635135)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  13. 153
    Trends in the relative frequency of FL among the incident NHL cases according to racial groups for the period 2008–2017.

    Trends in the relative frequency of FL among the incident NHL cases according to racial groups for the period 2008–2017. by Yu-Chieh Su (138988)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 154
    The change of disease burden of CRD by sex in Fujian, 1990-2021.

    The change of disease burden of CRD by sex in Fujian, 1990-2021. by Yanrong Yin (14292683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 155
    The change of disease burden of CRD by categories in Fujian, 1990-2021.

    The change of disease burden of CRD by categories in Fujian, 1990-2021. by Yanrong Yin (14292683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 156
    The change of disease burden of CRD in different region, 1990-2021.

    The change of disease burden of CRD in different region, 1990-2021. by Yanrong Yin (14292683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 157
    Interrupted time series analysis of monthly drug consumption measured by DDD/1000P in: (B) Drugs active on digestive system.

    Interrupted time series analysis of monthly drug consumption measured by DDD/1000P in: (B) Drugs active on digestive system. by Minh-Anh Le-Dang (17817332)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 158
    The timeline of COVID-19 in Ho Chi Minh City.

    The timeline of COVID-19 in Ho Chi Minh City. by Minh-Anh Le-Dang (17817332)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 159
    Interrupted time series analysis of monthly drug consumption measured by DDD/1000P in: (C) Analgesics, antipyretics; non-steroidal anti-inflammatory drugs and other drugs related to arthritis.

    Interrupted time series analysis of monthly drug consumption measured by DDD/1000P in: (C) Analgesics, antipyretics; non-steroidal anti-inflammatory drugs and other drugs related t... by Minh-Anh Le-Dang (17817332)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 160
    Interrupted time series analysis of monthly drug consumption measured by DDD/1000P in: (D) Hormon and drugs active on endocrine system.

    Interrupted time series analysis of monthly drug consumption measured by DDD/1000P in: (D) Hormon and drugs active on endocrine system. by Minh-Anh Le-Dang (17817332)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: